These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [On qualitative demonstration of tuberculostatics in the control of taking of drugs]. Grunert M, Reutgen H, Iwainsky H. Z Tuberk Erkr Thoraxorg; 1965 Jul; 124(3):141-8. PubMed ID: 5899136 [No Abstract] [Full Text] [Related]
13. [Intravenous hormono-chemotherapy of pulmonary tuberculosis in case of drug-resistant mycobacteria]. Repin IuM, Saburenkova EP. Vrach Delo; 1969 Feb; 2():61-3. PubMed ID: 4305290 [No Abstract] [Full Text] [Related]
14. Limitations of the clinical activity of cycloserine therapy. Appearance of resistance to cycloserine when used alone and in combination with other drugs. Molina C. Scand J Respir Dis Suppl; 1970 Feb; 71():296-305. PubMed ID: 5272000 [No Abstract] [Full Text] [Related]
18. [Improved therapy of tuberculosis with a well tolerated INH derivative (INHG)]. Sighart H, Opl G. Wien Klin Wochenschr; 1969 Nov 04; 81(46):840-1. PubMed ID: 5380791 [No Abstract] [Full Text] [Related]
19. Position of cycloserine in the treatment of pulmonary tuberculosis. Meyer A, Nadjar G. Scand J Respir Dis Suppl; 1970 Nov 04; 71():139-43. PubMed ID: 5271974 [No Abstract] [Full Text] [Related]
20. [Ethionamide and tubazid in the therapy of pulmonary tuberculosis]. Pudoĭ NM, Iampol'skaia SA. Klin Med (Mosk); 1969 Dec 04; 47(12):74-9. PubMed ID: 5382417 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]